Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Betamethasone in Localized Alopecia Areata
NCT02350023Phase 4Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of latanoprost in alopecia areata (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Number of patients with hair regrowth at 4 months. Started Sep 2014; status: completed.
02
Drugs
latanoprost
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT02350023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350023.